Compare SYF & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYF | GEHC |
|---|---|---|
| Founded | 1932 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 27.9B |
| IPO Year | 2014 | 2022 |
| Metric | SYF | GEHC |
|---|---|---|
| Price | $76.96 | $74.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | $84.83 | ★ $88.38 |
| AVG Volume (30 Days) | 3.1M | ★ 4.4M |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.60% | 0.24% |
| EPS Growth | ★ 8.54 | 4.84 |
| EPS | ★ 4.85 | 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $84.92 | $7.12 |
| Revenue Next Year | $5.11 | $4.45 |
| P/E Ratio | ★ $16.42 | $87.79 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $63.08 | $58.75 |
| 52 Week High | $88.77 | $89.77 |
| Indicator | SYF | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 66.81 |
| Support Level | $68.82 | $69.17 |
| Resistance Level | $79.93 | $75.95 |
| Average True Range (ATR) | 1.66 | 1.51 |
| MACD | -0.11 | 0.22 |
| Stochastic Oscillator | 20.35 | 82.67 |
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).